Literature DB >> 8675619

Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.

P H Weinstock1, C L Bisgaier, K Aalto-Setälä, H Radner, R Ramakrishnan, S Levak-Frank, A D Essenburg, R Zechner, J L Breslow.   

Abstract

Lipoprotein lipase (LPL)-deficient mice have been created by gene targeting in embryonic stem cells. At birth, homozygous knockout pups have threefold higher triglycerides and sevenfold higher VLDL cholesterol levels than controls. When permitted to suckle, LPL-deficient mice become pale, then cyanotic, and finally die at approximately 18 h of age. Before death, triglyceride levels are severely elevated (15,087 +/- 3,805 vs 188 +/- 71 mg/dl in controls). Capillaries in tissues of homozygous knockout mice are engorged with chylomicrons. This is especially significant in the lung where marginated chylomicrons prevent red cell contact with the endothelium, a phenomenon which is presumably the cause of cyanosis and death in these mice. Homozygous knockout mice also have diminished adipose tissue stores as well as decreased intracellular fat droplets. By crossbreeding with transgenic mice expressing human LPL driven by a muscle-specific promoter, mouse lines were generated that express LPL exclusively in muscle but not in any other tissue. This tissue-specific LPL expression rescued the LPL knockout mice and normalized their lipoprotein pattern. This supports the contention that hypertriglyceridemia caused the death of these mice and that LPL expression in a single tissue was sufficient for rescue. Heterozygous LPL knockout mice survive to adulthood and have mild hypertriglyceridemia, with 1.5-2-fold elevated triglyceride levels compared with controls in both the fed and fasted states on chow, Western-type, or 10% sucrose diets. In vivo turnover studies revealed that heterozygous knockout mice had impaired VLDL clearance (fractional catabolic rate) but no increase in transport rate. In summary, total LPL deficiency in the mouse prevents triglyceride removal from plasma, causing death in the neonatal period, and expression of LPL in a single tissue alleviates this problem. Furthermore, half-normal levels of LPL cause a decrease in VLDL fractional catabolic rate and mild hypertriglyceridemia, implying that partial LPL deficiency has physiological consequences.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8675619      PMCID: PMC185959          DOI: 10.1172/JCI118319

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Embedding in epoxy resins for ultrathin sectioning in electron microscopy.

Authors:  K C RICHARDSON; L JARETT; E H FINKE
Journal:  Stain Technol       Date:  1960-11

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size.

Authors:  E Zsigmond; E Scheffler; T M Forte; R Potenz; W Wu; L Chan
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

4.  The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity.

Authors:  D N Nevin; J D Brunzell; S S Deeb
Journal:  Arterioscler Thromb       Date:  1994-06

5.  Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior.

Authors:  K Aalto-Setälä; C L Bisgaier; A Ho; K A Kieft; M G Traber; H J Kayden; R Ramakrishnan; A Walsh; A D Essenburg; J L Breslow
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia.

Authors:  E Gagné; J Genest; H Zhang; L A Clarke; M R Hayden
Journal:  Arterioscler Thromb       Date:  1994-08

7.  Molecular cloning and structural analysis of the human gene encoding cellular retinaldehyde-binding protein.

Authors:  R Intres; S Goldflam; J R Cook; J W Crabb
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis.

Authors:  G Renier; E Skamene; J B DeSanctis; D Radzioch
Journal:  Arterioscler Thromb       Date:  1993-02

9.  Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.

Authors:  S Levak-Frank; H Radner; A Walsh; R Stollberger; G Knipping; G Hoefler; W Sattler; P H Weinstock; J L Breslow; R Zechner
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Lipoprotein lipase (LpL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LpL increases LDL accumulation in vascular tissue.

Authors:  J C Rutledge; I J Goldberg
Journal:  J Lipid Res       Date:  1994-07       Impact factor: 5.922

View more
  101 in total

Review 1.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

Review 2.  Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism.

Authors:  Miklós Péterfy
Journal:  Biochim Biophys Acta       Date:  2011-10-12

3.  Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

Authors:  Jennifer M MacArthur; Joseph R Bishop; Kristin I Stanford; Lianchun Wang; André Bensadoun; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 4.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

Review 5.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

6.  Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oil.

Authors:  Roberto Martínez-Beamonte; María A Navarro; Sergio Acin; Natalia Guillén; Cristina Barranquero; Carmen Arnal; Joaquín Surra; Jesus Osada
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

7.  Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia.

Authors:  M Merkel; P H Weinstock; T Chajek-Shaul; H Radner; B Yin; J L Breslow; I J Goldberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.

Authors:  S F C Vaessen; G M Dallinga-Thie; C J D Ross; L J Splint; L W Castellani; P C N Rensen; M R Hayden; F G Schaap; J A Kuivenhoven
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

Review 9.  GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.

Authors:  Anne P Beigneux; Brandon S J Davies; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-10-14       Impact factor: 5.922

10.  Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.

Authors:  Toshihiro Sakurai; Akiko Sakurai; Boris L Vaisman; Marcelo J Amar; Chengyu Liu; Scott M Gordon; Steven K Drake; Milton Pryor; Maureen L Sampson; Ling Yang; Lita A Freeman; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.